{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:54:01Z","timestamp":1790481241806,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01225","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T04:59:07Z","timestamp":1541048347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Imepitoin Shows Benzodiazepine-Like Effects in Models of Anxiety"],"prefix":"10.3389","volume":"9","author":[{"given":"Odilo","family":"Engel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Masic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Landsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Rundfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.nbd.2013.10.006","article-title":"Discovery of novel anxiolytic agents \u2014 The trials and tribulations of pre-clinical models of anxiety.","volume":"61","author":"Andrews","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jveb.2012.10.008","article-title":"Development and validation of a novel laboratory model of sound-induced fear and anxiety in Beagle dogs.","volume":"8","author":"Araujo","year":"2013","journal-title":"J. Vet. Behav. Clin. Appl. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0091-3057(82)90260-X","article-title":"Benzodiazepine effects upon geller-seifter conflict test in rats: analysis of individual variability.","volume":"17","author":"Babbini","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cvsm.2013.02.006","article-title":"Anesthesia and pain management for small animals.","volume":"43","author":"Beckman","year":"2013","journal-title":"Vet. Clin. North Am."},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test.","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"B6","first-page":"1144","article-title":"Oral transmucosal administration of dexmedetomidine for sedation in 4 dogs.","volume":"56","author":"Cohen","year":"2015","journal-title":"Can. Vet. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.physbeh.2017.04.008","article-title":"Physiological and behavioral reactivity to stress in thunderstorm-phobic dogs and their caregivers.","volume":"95","author":"Dreschel","year":"2005","journal-title":"Appl. Anim. Behav. Sci."},{"key":"B8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1476-5381.1978.tb07001.x","article-title":"Can social interaction be used to measure anxiety?","volume":"62","author":"File","year":"1978","journal-title":"Br. J. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"A review of 25 years of the social interaction test.","volume":"463","author":"File","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/BF00429273","article-title":"The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat.","volume":"1","author":"Geller","year":"1960","journal-title":"Psychopharmacologia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery.","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety.","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF02244836","article-title":"Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.","volume":"114","author":"Jones","year":"1994","journal-title":"Psychopharmacology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/vr.104045","article-title":"Dexmedetomidine oromucosal gel for noiseassociated acute anxiety and fear in dogs\u2014a randomised, double-blind, placebo-controlled clinical study.","volume":"180","author":"Korpivaara","year":"2017","journal-title":"Vet. Rec."},{"key":"B15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/emboj\/18.4.833","article-title":"Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons.","volume":"18","author":"Liss","year":"1999","journal-title":"EMBO J."},{"key":"B16","first-page":"131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety.","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Sci. Prog."},{"key":"B17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/JCP.0b013e3181d41f41","article-title":"Long-term benzodiazepine use and salivary cortisol: the Netherlands Study of Depression and Anxiety (NESDA).","volume":"30","author":"Manthey","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0165-0327(00)00344-X","article-title":"Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety.","volume":"61","author":"McNaughton","year":"2000","journal-title":"J. Affect. Disord."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-017-1098-0","article-title":"The use of imepitoin (Pexion) on fear and anxiety related problems in dogs - a case series.","volume":"13","author":"McPeake","year":"2017","journal-title":"BMC Vet. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0014-2999(03)01275-5","article-title":"The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines.","volume":"463","author":"Millan","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1590\/S0100-879X1997000300002","article-title":"Animal models of anxiety: an ethological perspective.","volume":"30","author":"Rodgers","year":"1997","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/jvp.12117","article-title":"Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs.","volume":"37","author":"Rundfeldt","year":"2014","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40263-013-0129-z","article-title":"The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy.","volume":"28","author":"Rundfeldt","year":"2014","journal-title":"CNS Drugs"},{"key":"B24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF02245313","article-title":"Dexmedetomidine synergism with midazolam in the elevated plus-maze test in rats.","volume":"108","author":"Salonen","year":"1992","journal-title":"Psychopharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3940(98)00186-4","article-title":"The antiepileptic drug AWD 131-138 stimulates different recombinant isoforms of the rat GABA(A) receptor through the benzodiazepine binding site.","volume":"245","author":"Sigel","year":"1998","journal-title":"Neurosci. Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.rvsc.2012.02.017","article-title":"Cortisol levels in hair reflect behavioural reactivity of dogs to acoustic stimuli.","volume":"94","author":"Siniscalchi","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","article-title":"Anxioselective anxiolytics: on a quest for the Holy Grail.","volume":"33","author":"Skolnick","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-02912-7","author":"Stein","year":"2010","journal-title":"Behavioral Neurobiology of Anxiety and Its Treatment."},{"key":"B29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1749-6632.1993.tb49931.x","article-title":"The Locus Coeruleus as a Site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responsesa.","volume":"697","author":"Valentino","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents.","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coph.2005.08.005","article-title":"GABA-A receptors: a viable target for novel anxiolytics?","volume":"6","author":"Whiting","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.applanim.2016.03.004","article-title":"Validation of modified open field behaviour as a measure of trait anxiety in the dog.","volume":"179","author":"Wormald","year":"2016","journal-title":"Appl. Anim. Behav. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01225\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T04:59:10Z","timestamp":1541048350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01225\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":32,"alternative-id":["10.3389\/fphar.2018.01225"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01225","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"article-number":"1225"}}